Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4120272
Reference Type
Journal Article
Title
Determination of Maleic Anhydride in Workplace Air by Reversed-Phase High-Performance Liquid Chromatography
Author(s)
Geyer, R; Saunders, GA
Year
1986
Is Peer Reviewed?
1
Journal
Journal of Chromatography
ISSN:
0021-9673
Report Number
NIOSH/00164844
Volume
368
Issue
2
Page Numbers
456-458
Abstract
An improvement of the current NIOSH high performance liquid chromatography (HPLC) procedure for analyzing airborne maleic-anhydride (108316) was described, which uses a simpler mobile phase, 0.1 percent phosphoric-acid in distilled water. The mobile phase was also used as the absorbing solution to collect the airborne maleic-anhydride. This mobile phase suppressed the ionization of maleic-acid sufficiently for the carboxylic-acid to have adequate retention of the reversed phase column. At a flow rate of 0.7 milliliters/minute, maleic-acid had a retention time of 3.2 minutes and was baseline separated from its structural isomer, fumaric-acid, which had a retention time of 4.7 minutes. The run time for the analysis was 5 minutes compared with over 8 minutes for the current NIOSH HPLC procedure. The conversion of maleic-anhydride to maleic-acid in the mobile phase was quantitative at the 0.05, 0.10, and 0.20 milligram (mg) levels. The relative standard deviation for injection of the 0.05, 0.10 and 0.20mg/15milliliters (ml) maleic-anhydride standards was 3.3, 1.5, and 1.9 percent, respectively. A chromatogram was presented of an air sample taken while an operator in a paint factory was adding maleic-anhydride to a polyester resin kettle. The linearity of the detector response for maleic-anhydride, measured as maleic-acid, was confirmed in the range 0.05 to 0.20mg/15ml standard solution.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity